Author: OurCrowd

[InsideTracker in PR Newswire] InsideTracker raises $15m to drive continued innovation and delivery of its leading AI platform for personalized nutrition and healthspan optimization

Sep 8, 2022 | ,

CAMBRIDGE, Mass., Sept. 8, 2022 /PRNewswire/ — InsideTracker, the leading healthspan optimization platform, announced today that it has raised $15M in Series B funding in a round led by PeakBridge with participation from Cornucopian Capital and OurCrowd, renewed participation from BASF Venture Capital GmbH, and the continued support of existing investors. Read more...

Read More

[ThetaRay in Business Wire] ThetaRay AI tech to monitor African payments for ARCA

Sep 8, 2022 | ,

NEW YORK & TEL AVIV, Israel & LAGOS, Nigeria–(BUSINESS WIRE)–ThetaRay, a leading provider of AI-powered transaction monitoring technology, today announced that ARCA, a premier African payment services provider, will implement ThetaRay’s advanced SONAR SaaS anti-money laundering (AML) and sanctions list screening solution for transactions on its open AI-based platform. Read more...

Read More

[Highcon in Printing News] Highcon launches HighConnect performance reporting platform to drive production efficiencies in digital finishing

Sep 8, 2022 |

The first-of-its-kind study examined the impact of analogue and digital creasing lines on the performance of corrugated cardboard and finished boxes.Highcon Systems Ltd. today announces the launch of HighConnect, a cloud-based data information platform that allows users to monitor their Highcon system production performance. Read...

Read More

[D-ID in BusinessWire] Skilldora partners with D-ID, launches first e-Learning platform & app to use A.I. Instructors in the U.S.

Sep 8, 2022 |

FORT MILL, S.C. & TEL AVIV, Israel–(BUSINESS WIRE)–Skilldora, an Ed-Tech startup based in Fort Mill, S.C., known for its modernized app-based eLearning community, today announced a partnership with D-ID, using its Creative Reality™ technology to deliver courses exclusively by A.I. Instructors, also referred to as digitally created humans. Read...

Read More

[Alpha Tau in GlobeNewswire] Alpha Tau announces the acceptance in major peer-reviewed journals (International Journal of Radiation Oncology, Biology, Physics, and Frontiers in Oncology) of two landmark pre-clinical studies demonstrating significant potential synergies between the Alpha DaRT treatment and standard-of-care immunotherapy, chemotherapy and anti-angiogenic therapy

Sep 8, 2022 |

JERUSALEM, Sept. 08, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”) (Nasdaq: DRTS and DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the acceptance of two landmark pre-clinical studies in major peer-reviewed journals, both demonstrating the significant potential synergies between Alpha DaRT therapy and standard-of-care solid tumor therapies used today. Read...

Read More